Pirenzepine

insulin ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 12460323 Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment. 2002 Dec 3
2 9075065 Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesity. 1997 Jan 1
3 8834976 Reduced growth hormone secretion improves insulin sensitivity in adolescent girls with type 1 diabetes. 1996 Jan 2
4 7516827 Acute cholinergic blockade with low dose pirenzepine reduces the insulin and glucose responses to a mixed meal in obese women with the polycystic ovary syndrome. 1994 May 5
5 8005563 Pirenzepine decreases basal and stimulated GH secretion in patients with type 2 (non-insulin-dependent) diabetes mellitus. 1994 Mar 1
6 1482018 [Nocturnal use of pirenzepine in young insulin dependent diabetics. Results of a 6-months treatment period]. 1992 Dec 1
7 1633930 [Role of growth hormone in the pathogenesis of dawn phenomenon in IDDM]. 1992 Jun 20 3
8 1889143 Cholinergic blockade with pirenzepine induces dose-related reduction in glucose and insulin responses to a mixed meal in normal subjects and non-insulin dependent diabetics. 1991 Jul 3
9 2667925 Early-morning hyperglycemia in IDDM. Acute effects of cholinergic blockade. 1989 Jul-Aug 1
10 2691121 Cholinergic blockade with pirenzepine improves carbohydrate tolerance and abolishes the GH response to meals in normal subjects. 1989 May 1
11 2918051 Chronic treatment with pirenzepine decreases growth hormone secretion in insulin-dependent diabetes mellitus. 1989 Feb 1
12 3517121 Muscarinic cholinergic modulation of insulin response to an intravenous glucose tolerance test in normal man. 1986 Feb 2
13 6957978 The effect of different doses of pirenzepine on gastric secretion stimulated by modified shamfeeding in man. 1982 1
14 396660 Inhibition of pentagastrin and insulin-stimulated gastric secretion by pirenzepine in healthy and duodenal ulcer subjects. 1979 2
15 493866 The effect of pirenzepine on basal, pentagastrin- and insulin-stimulated gastric acid secretion in patients with peptic ulcer disease. 1979 1